Most read
AstraZeneca’s Tagrisso plus chemotherapy approved in Japan and China
AstraZeneca announced that its cancer drug Tagrisso, in combination with pemetrexed and platinum-based chemotherapy, has received regulatory approvals in both…
Novo Nordisk to invest $4.1bn to expand manufacturing in US
Danish pharmaceutical company Novo Nordisk has unveiled its plans to invest $4.1bn to build a second fill and finishing manufacturing…
Japan’s MHLW approves GSK’s Omjjara for myelofibrosis treatment
GSK has received approval from the Japan’s Ministry of Health, Labour and Welfare (MHLW) for Omjjara (momelotinib) to treat patients…
Takeda gets EC approval for Fruzaqla to treat metastatic colorectal cancer
Japanese pharmaceutical company Takeda has received the European Commission (EC) approval for Fruzaqla (fruquintinib) to treat a type of metastatic…
BMS’ Krazati secures FDA accelerated nod for KRAS G12C-mutated CRC
Bristol Myers Squibb (BMS) has secured accelerated approval from the US Food and Drug Administration (FDA) for Krazati (adagrasib) in…
Sarepta secures expanded FDA approval for its DMD drug Elevidys
US-based biotechnology company Sarepta Therapeutics has received the US Food and Drug Administration (FDA) approval for an expansion to the…
Gilead’s lenacapavir meets key efficacy endpoints of superiority in Phase 3 HIV trial
Gilead Sciences has announced positive outcomes from the Phase 3 PURPOSE 1 trial of lenacapavir, demonstrating its efficacy for HIV…
Woolsey’s Bravyl shows positive outcomes in ALS clinical study
US-based drug development company Woolsey Pharmaceuticals has announced positive outcomes for Bravyl in amyotrophic lateral sclerosis (ALS) patients, from a…
Dizal gains Chinese approval for golidocitinib in relapsed or refractory PTCL
Dizal has gained approval in China for its Janus kinase 1 (JAK1) selective inhibitor golidocitinib in relapsed or refractory peripheral…
Roche, Ascidian partner to develop RNA therapies for neurological diseases
US-based biotechnology company Ascidian Therapeutics has partnered with Swiss pharmaceutical firm Roche, for the discovery and development of RNA therapeutics…